Citadel Advisors’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Buy
+13,897
New +$126K ﹤0.01% 12464
2026
Q1
Sell
-20,974
Closed -$202K 13462
2025
Q4
$202K Buy
+20,974
New +$197K ﹤0.01% 11022
2025
Q3
Sell
-10,107
Closed -$95.5K 13292
2025
Q2
$95.5K Buy
+10,107
New +$96.2K ﹤0.01% 11388
2023
Q2
Sell
-17,192
Closed -$173K 14682
2023
Q1
$173K Sell
17,192
-9,656
-36% -$98.1K ﹤0.01% 10409
2022
Q4
$276K Buy
+26,848
New +$270K ﹤0.01% 9500
2021
Q3
Sell
-11,268
Closed -$152K 14114
2021
Q2
$152K Buy
+11,268
New +$148K ﹤0.01% 12492

Other funds holding GRX

Citadel Advisors's GRX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Gabelli Healthcare & Wellness Trust (GRX) in Q2 2026: 13,897 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #12464 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in GRX as recently as Q4 2025.

Citadel Advisors first reported a position in GRX in Q2 2021 and has held it in 6 quarters since. The position peaked at $276K in Q4 2022. 51 funds tracked by Wall St. Rank hold GRX as of Q2 2026.

  • Citadel Advisors held 13,897 shares of Gabelli Healthcare & Wellness Trust worth $131K as of Q2 2026.
  • Gabelli Healthcare & Wellness Trust was a new Citadel Advisors position in Q2 2026.
  • Gabelli Healthcare & Wellness Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12464 holding.
  • Citadel Advisors first reported a position in Gabelli Healthcare & Wellness Trust in Q2 2021 and has held it in 6 quarters since.
  • Citadel Advisors's Gabelli Healthcare & Wellness Trust position peaked at $276K in Q4 2022.
  • 51 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.